Equasym – Shire Enters ADHD Europe
ByShire is the company that brought Adderall, Adderall XR, Vyvanse & Daytrana to market. Although the head office is based in the UK, they do not have any ADHD products in the European Community.
In February 2009, Shire purchased the rights to market Equasym in Europe (for $55 Million Euros). Equasym is a mid-acting methylphenidate product – similar in action to Metadate CD.
This will give Shire the opportunity to market in the ADHD treatment area in Europe. Presumably – this is a strategic approach to allow them to bring their own products to market in Europe (maybe Vyvanse? Daytrana?).
As Shire has brought many products to help provide treatment options for people with ADD/ADHD in the US and other countries – hopefully this move is an indication of more support to come for people with ADD/ADHD in Europe.
Click here to read a news report on this issue.
Technorati Tags: Equasym, Metadate CD, Adderall XR, Vyvanse, Shire, Europe, ADD, ADHD, Medication
